How acceptable are innovative health-care technologies? A survey of public beliefs and attitudes in England and Wales

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.socscimed.2004.08.058 Byline: Michael Calnan (a), David Montaner (b), Rob Horne (b) Keywords: Genetics; New technologies; Public attitudes; Trust; UK Abstract: There has been a continuing debate about the extent to which the public finds health-care technological innovation acceptable. The public's ambivalence about scientific medicine may have been exacerbated, more recently, by developments such as the introduction of the 'new genetics' with their associated ethical and social implications and the claims that public trust in health care and practitioners and, more widely, in society has been eroded. The aim of this paper is to examine public attitudes to a range of innovative health-care technologies to see whether (i) certain technologies are perceived as particularly problematic, and (ii) attitudes to new health-care technologies are associated more broadly with beliefs about science, trust in health care and social trust, and perceptions of the benefits and risks of complementary and alternative medicine versus orthodox (technological) medicine. These questions are examined through a statistical analysis of data collected in a national, postal survey of the adult population (n=1187) in England and Wales. The results showed public ambivalence about new health-care technologies, although genetic technologies, as a whole, were not seen to be problematic and their acceptability depended on their ability to control serious diseases. However, there was a level of consistency in attitude across the different technologies. Those consistently against new health-care technologies were also more likely to be suspicious of science, and doubtful about the benefits of other established, orthodox technologies (screening; medications) and to have less trust in health and health-care practitioners. Author Affiliation: (a) MRC HSRC, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, P.O. Box 901, Bristol BS8 2PR, UK (b) Centre for Health Care Research, Postgraduate Medical School, University of Brighton, Falmer Campus, Falmer, Brighton, East Sussex BN1 9PH, UK